🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

PRESS DIGEST- New York Times business news - April 26

Published 2016-04-26, 12:15 a/m
© Reuters.  PRESS DIGEST- New York Times business news - April 26
PSON
-
BHC
-
SRPT
-
CHTR
-

April 26 (Reuters) - The following are the top stories on
the New York Times business pages. Reuters has not verified
these stories and does not vouch for their accuracy.

- Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO said on
Monday that Joseph C. Papa, the head of the drug maker Perrigo
PRGO.N , would take over as chief executive, replacing the
embattled J. Michael Pearson (LON:PSON).

Advisers to the U.S. Food and Drug Administration voted on
Monday not to recommend approval of Sarepta Therapeutics'
SRPT.O drug for Duchenne muscular dystrophy.

U.S. federal regulators on Monday moved to approve Charter
Communications CHTR.O ' $65.5 billion acquisitions of Time
Warner Cable TWC.N and Bright House Networks, enabling the
creation of a new cable giant as the industry focuses more on
broadband as traditional TV declines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.